|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Zavante Therapeutics, Inc.
| | | Year Established: | 2015 | Main Contact: | Cam Gallagher, CBO | | Other Contacts: | EJ Ellis-Grosse, CSO Jim Breitmeyer, Acting CMO Kristina Haeckl, Acting VP Regulatory Affairs Cam Garner, Chairman Ted Schroeder, President & CEO Kevin Finney, COO
| | Company Description | Zavante Therapeutics is a privately-held, clinical late-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients. The lead product candidate, ZTI-01, is a novel injectable antibiotic with a broad spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains where current therapeutic choices are severely limited. | |
|
|
|
|
|